Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Affamed - Digital Therapeutics Alliance
Working at AffaMed Therapeutics | Glassdoor
AffaMed Technologies, a joint venture established between AffaMed ...
AffaMed Therapeutics Announces Strategic Partnership with Primal ...
AffaMed Therapeutics 与 SIFI 宣布成立合资公司-公司新闻-AffaMed蔼睦医疗
AffaMed Therapeutics Careers | Levels.fyi
AffaMed Technologies Announces the First Implantation in the China ...
AIER and AffaMed Therapeutics Reach Strategic Cooperation in Boao ...
AffaMed Therapeutics 和 SIFI 的合資企業 Affamed Technologies 宣佈在中國成功完成 MINI ...
AffaMed Therapeutics Co., Ltd. (上海蔼睦医疗科技有限公司) - 药物管线_专利_临床试验_投融营收_最新药物 ...
AffaMed Therapeutics announces first patient dosed in the Phase 1 ...
AffaMed Therapeutics 和 Allgenesis Biotherapeutics 宣布达成 AG-73305 大中华区许可 ...
AffaMed Therapeutics Announces Clinical Trial Application Approval in ...
Proud milestone for AffaMed Therapeutics as we advance our first NDA ...
#affamed | AffaMed Therapeutics
AffaMed Therapeutics on LinkedIn: #iols #edof
NMPA Nods AffaMed Therapeutics Clinical Trial application For dry AMD
AffaMed Therapeutics 宣布用于治疗帕金森病的AM006在中国获批开展IIb临床研究-美通社PR-Newswire
AffaMed Therapeutics宣布与北京天坛医院及北京无疆科技签订战略合作协议 - 知乎
AffaMed Therapeutics on LinkedIn: #cataract #refractivesurgery # ...
AffaMed Therapeutics announces the completion of patient enrollment in ...
AffaMed receives NMPA approval for DEXTENZA study in China
AffaMed Therapeutics is pleased to join other #healthcare leaders at ...
#dme | AffaMed Therapeutics
AffaMed Therapeutics on LinkedIn: To date, there is no approved and ...
AffaMed announces dosing of first subject in retinal disease therapy trial
AffaMed Therapeutics on LinkedIn: AffaMed Therapeutics is looking ...
AffaMed Therapeutics on LinkedIn: #ophthalmology #cataractsurgery
AffaMed Therapeutics on LinkedIn: #jpm2023
AffaMed Technologies Announces Licensing of EVOLUX®- a novel extended ...
AffaMed Therapeutics Announces Partner Vistagen Reports Positive Top ...
AffaMed Therapeutics 旗下合资公司在北京落户
AffaMed inks agreement with Beijing Tiantan Hospital & IBT to promote ...
VTGN | AffaMed Therapeutics Announces Partner Vistagen Reports Positive ...
产品管线-AffaMed蔼睦医疗
AffaMed蔼睦医疗
Affimed Therapeutics | EquityNet
FDA grants IND clearance for AffaMed's AM712 to treat retinal vascular ...
核心团队-AffaMed蔼睦医疗
Pipeline-AffaMed蔼睦医疗
加入我们-AffaMed蔼睦医疗
使命和愿景-AffaMed蔼睦医疗
易路联手AffaMed：开启数字化之旅，为医疗创新插上“数字之翼”_推荐_i黑马
推进神经疾病数字化治疗！AffaMed与北京天坛医院、IBT达成合作医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
易路聯手AffaMed：開啟數位化之旅，為醫療創新插上「數字之翼」 - 每日頭條
易路联手AffaMed：开启数字化之旅，为医疗创新插上“数字之翼”-美通社PR-Newswire
Affimed Therapeutics 2018 Q3 - Results - Earnings Call Slides (NASDAQ ...
无疆科技、天坛医院、AffaMed达成数字疗法战略合作-IBT无疆科技INFIBRAINTECH
商业拓展-合作伙伴-AffaMed蔼睦医疗
商业拓展-AffaMed蔼睦医疗
大事记-AffaMed蔼睦医疗
蔼睦医疗宣布头痛e站（头痛CDSS 2.0）正式发布-公司新闻-AffaMed蔼睦医疗
联系方式-AffaMed蔼睦医疗
中國藥企AffaMed Therapeutics與EverInsight Therapeutics合併 | NAI 500
#digitalmedicine #digitaltherapeutics #stroke #neurorehabilitation # ...
Contact-AffaMed蔼睦医疗
Affimed Announces Acimtamig and AlloNK® Combination Granted ...
Leadership-AffaMed蔼睦医疗
借助博鳌平台加快创新药械引入 AffaMed与两家眼科医院达成合作_凤凰网
Affimed Secures the US FDA’s Regenerative Medicine Advanced Therapy ...
Effective Q1 2024 Affimed NV Presentation Design for Cancer Therapies ...
AffaMed: IND Clearance for AM712 to Treat Retinal Diseases
Careers-AffaMed蔼睦医疗
商业拓展-合作伙伴-AffaMed
Business Development-Partnership-AffaMed蔼睦医疗
-306.jpg)
-557.jpg)
